Company registration number SC357141 (Scotland)
MANORPORT LIMITED
(T/A DUNAMIS PHARMACY)
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
PAGES FOR FILING WITH REGISTRAR
MANORPORT LIMITED
(T/A DUNAMIS PHARMACY)
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 7
MANORPORT LIMITED
(T/A DUNAMIS PHARMACY)
BALANCE SHEET
AS AT 31 DECEMBER 2024
31 December 2024
- 1 -
2024
2023
Notes
£
£
£
£
Fixed assets
Tangible assets
3
192,076
230,496
Current assets
Stocks
79,248
71,898
Debtors
4
540,088
496,575
Cash at bank and in hand
79,798
145,154
699,134
713,627
Creditors: amounts falling due within one year
5
(334,123)
(351,647)
Net current assets
365,011
361,980
Total assets less current liabilities
557,087
592,476
Creditors: amounts falling due after more than one year
6
(285,908)
(328,794)
Provisions for liabilities
(38,117)
(42,474)
Net assets
233,062
221,208
Capital and reserves
Called up share capital
8
2
2
Profit and loss reserves
233,060
221,206
Total equity
233,062
221,208

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The director acknowledges her responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

MANORPORT LIMITED
(T/A DUNAMIS PHARMACY)
BALANCE SHEET (CONTINUED)
AS AT 31 DECEMBER 2024
31 December 2024
- 2 -
The financial statements were approved and signed by the director and authorised for issue on 29 September 2025
Ms O Ogunnoiki
Director
Company Registration No. SC357141
MANORPORT LIMITED
(T/A DUNAMIS PHARMACY)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
- 3 -
1
Accounting policies
Company information

Manorport Limited is a private company limited by shares incorporated in Scotland. The registered office is 27 Elizabeth Drive, Bathgate, West Lothian, United Kingdom, EH48 1SJ.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

 

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Leasehold land and buildings
5% straight line
Fixtures and fittings
15% straight line
Motor vehicles
25% reducing balance

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.4
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

1.5
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

MANORPORT LIMITED
(T/A DUNAMIS PHARMACY)
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 4 -
1.6
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.7
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.8
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.9
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

1.10
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.11
Leases

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessees. All other leases are classified as operating leases.

 

Assets held under finance leases are recognised as assets at the lower of the assets fair value at the date of inception and the present value of the minimum lease payments. The related liability is included in the balance sheet as a finance lease obligation. Lease payments are treated as consisting of capital and interest elements. The interest is charged to profit or loss so as to produce a constant periodic rate of interest on the remaining balance of the liability.

MANORPORT LIMITED
(T/A DUNAMIS PHARMACY)
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 5 -
2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2024
2023
Number
Number
Total
13
14
3
Tangible fixed assets
Leasehold land and buildings
Fixtures and fittings
Motor vehicles
Total
£
£
£
£
Cost
At 1 January 2024
202,000
313,338
57,789
573,127
Disposals
-
0
(11,600)
-
0
(11,600)
At 31 December 2024
202,000
301,738
57,789
561,527
Depreciation and impairment
At 1 January 2024
141,400
159,772
41,459
342,631
Depreciation charged in the year
10,100
13,347
4,082
27,529
Eliminated in respect of disposals
-
0
(709)
-
0
(709)
At 31 December 2024
151,500
172,410
45,541
369,451
Carrying amount
At 31 December 2024
50,500
129,328
12,248
192,076
At 31 December 2023
60,600
153,566
16,330
230,496
4
Debtors
2024
2023
Amounts falling due within one year:
£
£
Trade debtors
107,365
105,880
Other debtors
432,723
390,695
540,088
496,575
MANORPORT LIMITED
(T/A DUNAMIS PHARMACY)
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 6 -
5
Creditors: amounts falling due within one year
2024
2023
£
£
Bank loans
42,886
42,886
Trade creditors
205,364
224,403
Taxation and social security
80,543
36,371
Other creditors
5,330
47,987
334,123
351,647
6
Creditors: amounts falling due after more than one year
2024
2023
£
£
Bank loans and overdrafts
285,908
328,794
Creditors which fall due after five years are as follows:
2024
2023
£
£
Payable by instalments
114,363
157,249
7
Secured debts

All amounts due to the bank, Santander UK PLC, are secured over the life assurance policy held by the director of the company.

 

Hire purchase liabilities are secured over assets in which they relate to.

 

8
Called up share capital
2024
2023
2024
2023
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary Shares of £1 each
2
2
2
2
9
Operating lease commitments

At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, as follows:

2024
2023
£
£
132,943
107,800
MANORPORT LIMITED
(T/A DUNAMIS PHARMACY)
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 7 -
10
Related party transactions

The following amounts were outstanding at the reporting end date:

2024
2023
Amounts due to related parties
£
£
Key management personnel
-
37,646

The following amounts were outstanding at the reporting end date:

2024
2023
Amounts due from related parties
£
£
Other related parties
373,304
366,961
Other information

The above loan is unsecured, interest free and has no fixed repayment terms.

11
Directors' transactions

The amount due to the director is unsecured, interest free and has no fixed terms of repayment.

Description
% Rate
Opening balance
Amounts advanced
Amounts repaid
Closing balance
£
£
£
£
Directors loan
-
(37,646)
163,868
(83,000)
43,222
(37,646)
163,868
(83,000)
43,222
12
Parent company

In the opinion of the director, O Ogunnoiki is the ultimate controlling party by virtue of her shareholding in the parent company, Manorport HC Limited, a company registered in Scotland.

2024-12-312024-01-01falsefalsefalse29 September 2025CCH SoftwareCCH Accounts Production 2025.100No description of principal activityMs O OgunnoikiSC3571412024-01-012024-12-31SC3571412024-12-31SC3571412023-12-31SC357141core:LandBuildingscore:LeasedAssetsHeldAsLessee2024-12-31SC357141core:FurnitureFittings2024-12-31SC357141core:MotorVehicles2024-12-31SC357141core:LandBuildingscore:LeasedAssetsHeldAsLessee2023-12-31SC357141core:FurnitureFittings2023-12-31SC357141core:MotorVehicles2023-12-31SC357141core:CurrentFinancialInstrumentscore:WithinOneYear2024-12-31SC357141core:CurrentFinancialInstrumentscore:WithinOneYear2023-12-31SC357141core:Non-currentFinancialInstrumentscore:AfterOneYear2024-12-31SC357141core:Non-currentFinancialInstrumentscore:AfterOneYear2023-12-31SC357141core:CurrentFinancialInstruments2024-12-31SC357141core:CurrentFinancialInstruments2023-12-31SC357141core:ShareCapital2024-12-31SC357141core:ShareCapital2023-12-31SC357141core:RetainedEarningsAccumulatedLosses2024-12-31SC357141core:RetainedEarningsAccumulatedLosses2023-12-31SC357141core:ShareCapitalOrdinaryShareClass12024-12-31SC357141core:ShareCapitalOrdinaryShareClass12023-12-31SC357141bus:Director12024-01-012024-12-31SC357141core:LandBuildingscore:LongLeaseholdAssets2024-01-012024-12-31SC357141core:FurnitureFittings2024-01-012024-12-31SC357141core:MotorVehicles2024-01-012024-12-31SC3571412023-01-012023-12-31SC357141core:LandBuildingscore:LeasedAssetsHeldAsLessee2023-12-31SC357141core:FurnitureFittings2023-12-31SC357141core:MotorVehicles2023-12-31SC3571412023-12-31SC357141core:LandBuildingscore:LeasedAssetsHeldAsLessee2024-01-012024-12-31SC357141core:WithinOneYear2024-12-31SC357141core:WithinOneYear2023-12-31SC357141core:Non-currentFinancialInstruments2024-12-31SC357141core:Non-currentFinancialInstruments2023-12-31SC357141bus:OrdinaryShareClass12024-01-012024-12-31SC357141bus:OrdinaryShareClass12024-12-31SC357141bus:OrdinaryShareClass12023-12-31SC357141core:KeyManagementPersonnel2023-12-31SC357141core:KeyManagementPersonnel2024-12-31SC357141core:OtherRelatedParties2024-12-31SC357141core:OtherRelatedParties2023-12-31SC357141bus:PrivateLimitedCompanyLtd2024-01-012024-12-31SC357141bus:SmallCompaniesRegimeForAccounts2024-01-012024-12-31SC357141bus:FRS1022024-01-012024-12-31SC357141bus:AuditExemptWithAccountantsReport2024-01-012024-12-31SC357141bus:FullAccounts2024-01-012024-12-31xbrli:purexbrli:sharesiso4217:GBP